InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
43%
T+90 mean return
-8.7%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Crystal Adam, Directeur Médical. Insider active across 2 companies, notably C4 Therapeutics, Inc.. In total, 21 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €131k. History available since 1 July 2021. The latest transaction was filed on 4 February 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations21 total
7,432 shares@ US$2.98816.4% of flowCommon StockSEC:0000950170-25-015693:0
53,015 shares0Common StockSEC:0000950170-25-014813:0
4,288 shares@ US$12.562638.2% of flowCommon StockSEC:0000950170-24-012991:0
46,599 shares0Common StockSEC:0000950170-24-011257:0
7,507 shares@ US$8.391445.4% of flowCommon StockSEC:0000950170-23-058314:0
81,250 shares0Common StockSEC:0000899243-23-006736:0
3,750 sharesCommon StockSEC:0001662579-23-000024:0
1,102 shares@ US$7.010.0039% mcap0.9% of flowCommon StockSEC:0001209191-22-036712:0
3,750 sharesCommon StockSEC:0001209191-22-032514:0
15,000 shares@ US$6.4911.2% of flowCommon StockSEC:0001209191-22-001700
15,000 shares@ US$6.490.047% mcap11.2% of flowCommon StockSEC:0001209191-22-001700:0
5,000 shares@ US$6.493.7% of flowCommon StockSEC:0001209191-21-071069
5,000 shares@ US$6.490.016% mcap3.7% of flowCommon StockSEC:0001209191-21-071069:0
10,000 shares@ US$6.490.030% mcap7.3% of flowCommon StockSEC:0001209191-21-060230:0
10,000 shares@ US$6.497.3% of flowCommon StockSEC:0001209191-21-060230
15,000 shares@ US$4.980.035% mcap8.4% of flowCommon StockSEC:0001209191-21-059512:0
15,000 shares@ US$4.988.4% of flowCommon StockSEC:0001209191-21-059512
15,000 shares@ US$4.980.034% mcap8.2% of flowCommon StockSEC:0001209191-21-049114:0
15,000 shares@ US$4.988.2% of flowCommon StockSEC:0001209191-21-049114
15,000 shares@ US$6.5010.7% of flowCommon StockSEC:0001209191-21-045691
15,000 shares@ US$6.500.044% mcap10.7% of flowCommon StockSEC:0001209191-21-045691:0
21 of 21 declarations
About Crystal Adam
Adam Crystal is the Chief Medical Officer at C4 Therapeutics, Inc. He oversees clinical activities and drug development strategies. His expertise in medicine and research is essential for guiding innovation and product safety.
